Researchers: Yaping Wang, Tianyun Gao, Bin Wang
Senescence is a hot topic nowadays, which shows the accumulation of senescent cells and inflammatory factors, leading to the occurrence of various senescence-related diseases. Although some methods have been identified to partly delay senescence, such as strengthening exercise, restricting diet, and some drugs, these only slow down the process of senescence and cannot fundamentally delay or even reverse senescence. Stem cell-based therapy is expected to be a potential effective way to alleviate or cure senescence-related disorders in the coming future. Mesenchymal stromal cells (MSCs) are the most widely used cell type in treating various diseases due to their potentials of self-replication and multidirectional differentiation, paracrine action, and immunoregulatory effects. Some biological characteristics of MSCs can be well targeted at the pathological features of aging. Therefore, MSC-based therapy is also a promising strategy to combat senescence-related diseases. Here we review the recent progresses of MSC-based therapies in the research of age-related diseases and the challenges in clinical application, proving further insight and reference for broad application prospects of MSCs in effectively combating senesce in the future.
References
- Nutritional components as mitigators of cellular senescence in organismal aging: a comprehensive review.
- Diet and aging.
- Microbiome and Human Aging: Probiotic and Prebiotic Potentials in Longevity, Skin Health and Cellular Senescence.
- The hallmarks of aging.
- Loss of epigenetic information as a cause of mammalian aging.
- Biomarkers of aging.
- Healthful aging mediated by inhibition of oxidative stress.
- A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice.
- Biomarkers of aging.
- Neurogenesis in aging and age-related neurodegenerative diseases.